How AI Can Improve Clinical Supply Chain Visibility
By Laura Hay, Senior Director, global program management at Trax Group | 2025 winner, everywoman Customer/Passenger (Leader) Award
Artificial intelligence has become one of the most discussed topics across nearly every industry, and supply chain management is no exception. While much of the conversation focuses on automation and workforce disruption, I believe the real opportunity lies elsewhere.
I don't see AI replacing supply chain professionals. I see it helping them make better decisions, faster.
Clinical supply chains are among the most complex operating environments in the world. They involve multiple countries, evolving regulatory requirements, temperature-sensitive products, changing patient enrollment rates, and a vast network of stakeholders working together to ensure critical therapies reach patients safely and on time.
In this environment, visibility is everything. It means understanding not only where product is, but whether it will arrive on time, remain within temperature specifications, and be available when the next patient visit occurs.
The challenge is that visibility has traditionally been limited by the sheer volume of data being generated across systems, suppliers, logistics providers, clinical sites, and sponsors. Supply chain teams often have access to enormous amounts of information, but turning that information into actionable insight remains difficult.
This is where AI has the potential to create meaningful value.
AI Can Augment Supply Professionals’ Expertise, Not Replace It
One of AI's greatest strengths is its ability to identify patterns that humans may not immediately recognize. While experienced supply chain professionals bring critical judgment and expertise to decision-making, AI can help process vast amounts of data in real time and surface trends that warrant attention.
For example, AI can analyze inventory levels across multiple locations and identify potential shortages before they occur. It can detect subtle shifts in patient enrollment trends that may impact future demand forecasts. It can evaluate transportation data and flag shipments that are at risk of delay before a disruption affects clinical operations.
These capabilities provide something that every supply chain leader values: time.
The earlier a potential issue is identified, the more options teams have available to address it. Instead of scrambling to respond to shortages, delays, or unexpected demand changes, organizations can take proactive measures to minimize risk and maintain continuity.
That shift from reactive management to proactive management may be one of the most important benefits AI brings to clinical supply chains.
Traditionally, many supply chain teams spend a significant portion of their time responding to issues after they occur. A shipment is delayed. Inventory levels fall below expectations. Patient enrollment accelerates faster than anticipated. Teams then work quickly to identify solutions and minimize the impact. While experienced professionals are highly skilled at managing these situations, reacting to problems after they emerge is often more expensive, more disruptive, and more stressful than preventing them in the first place.
AI offers the opportunity to provide earlier warning signals.
By continuously monitoring data across multiple sources, AI-powered tools can identify emerging risks and alert teams before those risks become operational challenges. This enables organizations to make adjustments earlier, allocate resources more effectively, and improve overall supply chain resilience.
Consider a global Phase 3 study where enrollment unexpectedly accelerates across multiple countries. Rather than simply reporting lower inventory levels, AI could recognize the trend, project future demand by depot, identify where shortages are most likely to occur, and recommend inventory reallocation before patient visits are impacted. Instead of reacting to a stockout, supply teams gain time to make informed decisions while preserving trial continuity. Importantly, AI should not be viewed as a replacement for human expertise.
Clinical supply chains require judgment, collaboration, and an understanding of nuances that technology alone cannot provide. Regulatory considerations, patient needs, site-specific challenges, and business priorities all require experienced professionals to evaluate options and make informed decisions.
The role of AI is to augment those professionals, not replace them.
When AI handles large-scale data analysis and pattern recognition, supply chain leaders can spend more time focusing on strategic decision-making, stakeholder engagement, and risk management. Technology becomes a tool that enhances human capabilities rather than substitutes for them.
Of course, realizing the full benefits of AI requires more than simply implementing new technology. Organizations must ensure they have strong data foundations, consistent processes, and clear governance structures in place. AI systems are only as effective as the data they analyze, which makes data quality and visibility critical prerequisites for success.
The organizations seeing the greatest results are not necessarily those with the most advanced AI tools. They are the ones that combine technology investments with trusted data, skilled teams, and a clear strategy for how insights will be used to drive decisions.
As clinical trials become increasingly global and complex, the need for visibility will only continue to grow. Supply chain leaders will be expected to manage greater uncertainty while maintaining efficiency, compliance, and patient-centric outcomes.
AI offers a powerful opportunity to meet those expectations. Not by replacing the expertise of supply chain professionals, but by helping them see risks sooner, make decisions with greater confidence, and focus their attention where it matters most.
In the end, the future of clinical supply chain management is not about humans versus technology. It is about leveraging both together to create more resilient, responsive, and patient-focused supply chains. The organizations that gain the greatest advantage from AI won't simply automate reports. They'll enable planners to make better decisions earlier, reducing disruptions before they affect clinical sites, investigators, or patients.
About The Author:
Laura Hay is a global supply chain leader specializing in program management, customer success, and account strategy. She has a proven track record of leading cross-functional teams to deliver complex, high-impact initiatives on time and within budget. Laura is known for building strong stakeholder relationships, driving operational excellence, and managing multimillion-dollar programs. She is passionate about connecting people, processes, and technology to build scalable, resilient supply chain solutions that deliver measurable business impact.